You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 21, November 26, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Lipids and Lipid Disorders
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Using Cardiovascular Age Equivalent to Close the Treatment Gap for Dyslipidemia

Charles B. Eaton, MD, MS

Arch Intern Med. 2007;167(21):2288.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The large gap in the quality of care received by the public1 and what we know from clinical trials to be efficacious treatment (evidence-based clinical guidelines) has prompted the study of finding more effective methods of getting evidence into practice.2-3 The CHECK-UP (Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients) Study in this issue of the Archives4 is an excellent example of this newly emerging discipline of implementation research. Grover et al4 present findings from a well-designed practice-based clinical trial that tested whether providing high-risk cardiovascular patients with a cardiovascular risk profile conceptualized as an "age equivalent" along with lipid profile results improved optimal cholesterol management consistent with the 2000 Canadian Working Group on Hypercholesterolemia and Other Dyslipidemias lipid guidelines in a primary care setting. Although the intention-to-treat analysis showed a small benefit after 1 year ({Delta} = –3.3 mg/dL [to convert to . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLE

Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy: The CHECK-UP Study: A Randomized Controlled Trial
Steven A. Grover, Ilka Lowensteyn, Lawrence Joseph, Mohammed Kaouache, Sylvie Marchand, Louis Coupal, Ghislain Boudreau, and for the Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group
Arch Intern Med. 2007;167(21):2296-2303.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.